MTOR and non-small cell lung carcinoma: The amount of 18F-FDG accumulation has been reported to be associated with molecules relevant to glucose metabolism, hypoxia (HIF-1α), angiogenesis (CD43, VEGF) and mTOR signaling pathway, and PTEN in NSCLC patients [8].